Back to Agenda
SESSION 9: EMA Policy 0070: Challenges and Techniques for Sponsors
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Merete-J Consulting, Denmark
With increasing regulations for transparency, how are patients and Ethics Committees impacted and do the regulations meet their needs?
Speaker(s)
Industry Experience with Preparing Documents for Submission
Nicole Hinton
Executive Director, Clinical Trial Transparency, Ultragenyx, United States
Mats Ericson, PhD
Director Regulatory Affairs, Amgen, France
Technical Solutions to Ease the Process of Redaction/ Anonymisation/Justification
Janice Branson, MSc
VP Head of Statistics, Immunology & Dermatology Unit, Novartis Pharma AG, Switzerland
Have an account?